Introduction: Cholecystitis is one of the most common diagnoses among patients referred to surgical emergencies with acute or recurrent abdominal pain. The mainstay of treatment for this disease is cholecystectomy, and the gold standard procedure is laparoscopic cholecystectomy. Pain which is the most common complication after laparoscopic cholecystectomy gives priority to the administration of the best pain relief medicine. This study aimed to compare the efficacy of diclofenac suppository with intravenous Meperidine for pain relief in opioid-dependent and independent patients undergoing laparoscopic cholecystectomy.
Introduction
Gallstone disease is a major health concern the world over. Gallstones are hardened deposits of the digestive fluid bile which can form within the gallbladder (1, 2) . In developed countries, the prevalence of gallstones among the adult population ranges from 10-15% and independent factors contributing to their development include family history, genetic predisposition, ethnic background, female gender, and age (3) (4) (5) . Most gallstones remain asymptomatic; however, up to 25% of them become symptomatic in the form of cholecystitis, cholangitis, or biliary pancreatitis (6) . When a patient develops symptoms or complications related to gallstones, surgical treatment remains the gold standard due to the high rate of medical re-admission (7) due to the same symptoms or pancreatitis or cholecystitis within a discrete-time frame. Furthermore, biliary colic is one of the most common precursors of lifethreatening gallstone-related complications (8) (9) (10) . In recent years, non-aggressive efforts have been made to treat gallstones as lithotripsy by electric waves and drug therapy for the elimination of biliary salts (11) . Open or laparoscopic cholecystectomy produces desirable long-term outcomes in patients with symptomatic stones; therefore, about 90% of patients with specific symptoms of gallstones after cholecystectomy are asymptomatic. Laparoscopic cholecystectomy is a common surgical procedure nowadays, in the United States, for instance, 90 percent of surgeries are laparoscopic cholecystectomy (12) . According to different health care systems, the recent data has revealed that consensus on a strategy favoring early laparoscopic cholecystectomy is very costeffective (13) (14) (15) . Laparoscopic cholecystectomy took the place of open cholecystectomy as the gold standard treatment for gallstones (16) . Although the laparoscopic procedure requires more operating time than the open procedure, it has many advantages over open cholecystectomy, such as no need of cutting the rectus abdominal muscle, less pain after surgery, shorter period of hospitalization, less incisional hernia, more beauty, and a faster return to work and social functioning (17) . Moreover, severe complications of laparoscopic cholecystectomy are rare, and mortality rate of laparoscopic cholecystectomy is less than open cholecystectomy (about 0.1 percent). In addition, wound infection and heartlung disease after laparoscopic cholecystectomy are much less, as compared to open procedures; however, the damage to extrahepatic biliary tract is more common (18, 19) . Laparoscopic cholecystectomy is now considered the gold standard therapy for symptomatic cholelithiasis and chronic cholecystitis (20) . All of the mentioned merits have made laparoscopic cholecystectomy a more efficient method with higher satisfaction among patients; however, it has some side effects. Although due to smaller incision, intercostal nerves and muscles of the abdominal wall are less painful than open surgery, there are still different causes of pain after surgery in these patients (21, 22) . Furthermore, one of the main concerns of surgeons is finding a way to better control postsurgical pain since the duration of hospital stay plays an essential role in pain, patient satisfaction, convalescence, and return to usual activities(23-26). Postoperative pain control methods include the regular use of selective and non-selective NSAID (a nonsteroidal anti-inflammatory drug), topical anesthetics, and intravenous opioids, such as morphine, meperidine, steroids, and clonidine (22, 24, (27) (28) (29) (30) (31) (32) . However, opioids which are used to control post-surgical pain as a routine procedure, especially in the early hours after surgery was associated with some restrictions (33) . Nonselective NSAID is another batch of drugs widely used to control postoperative pain in the process (34) (35) (36) . However, these drugs carry their own pitfalls and serious complications especially if used for the management of acute pain. This can be attributed to their effects on inhibition of Cyclooxygenase-I, and Cyclooxygenase-II in combination with their anti-inflammatory and analgesic activity. These complications include increased risk of bleeding in the upper gastrointestinal tract, acute renal failure, impaired platelet function followed by severe bleeding during or after surgery. Following these complications, COX-II-selective NSAIDs are more prefered than COX-II-non-selective NSAIDs in patients who are susceptible to upper gastrointestinal bleeding (37) . Many studies have been conducted on finding the best way to control pain after laparoscopic cholecystectomy. Joshi et al. (38) in a study conducted on 263 patients determined the effect of Parecoxib intravenous dose before surgery and continued oral therapy with Valdecoxib for the treatment of pain associated with elective laparoscopic cholecystectomy and their impact on the reduction of the need for opioids. The result of the mentioned study signified a 21% reduction of fentanyl administration in the patients who received Parecoxib, as compared to the placebo group. On the other hand, patients who received Valdecoxib after hospital discharge needed fewer analgesics supplements. In addition, the incidence of adverse effects in Parecoxib and Valdecoxib Downloaded from jsurgery.bums.ac.ir at 16:17 IRDT on Sunday March 22nd 2020 group was less, as compared to the placebo group (38) . In another study, Cheng et al. (39) evaluated the effectiveness of Celecoxib in the reduction of opioids consumption in patients undergoing laparoscopic cholecystectomy. The results of this study revealed that pain scores and morphine consumption in the two treatment groups were not statistically significant. Celecoxib can reduce opioid use to reduce pain in patients who had a laparoscopic cholecystectomy, and the combination of several techniques to relieve multi-factorial pain following laparoscopic cholecystectomy is more efficient (39) . Ariana and Rafei compared the postoperative analgesia in laparoscopic cholecystectomy using two methods, including bupivacaine in peritoneal and intravenous Meperidine. The results of the mentioned study suggested that oral analgesic requirements in the bupivacaine group were significantly lower than that of intravenous Meperidine. Moreover, nausea and vomiting in the first few hours in bupivacaine group were lower than that of intravenous Meperidine, and the patient's breathing in the peritoneal bupivacaine group was higher than that of intravenous Meperidine (40) . Soroush et al. in a study evaluated the effectiveness of Celecoxib in the reduction of pain in patients after laparoscopic cholecystectomy. The results showed that celecoxib administration before and after surgery had a significant effect on the reduction of analgesic consumption. The mean pain score showed a significant difference between the treatment group and the control group. In addition, a significant difference was observed between the treatment group and the control group concerning postsurgical nausea and vomiting, the length of hospital stay, and intestinal function (37) . The results of the study performed by Abdollahi et al. on the effect of two analgesic medication, including diclofenac suppository, and Meperidine on pain relief after inguinal hernia surgery, no statistically significant difference was observed between the two groups in terms of pain relief in the first 24 hours after surgery. According to the results of this study, diclofenac sodium can be used as an alternative to Meperidine to relieve pain after inguinal hernia surgery (41) . Despite the importance of postsurgical pain management and many studies performed in this field, selecting the right medication for the achievment of the optimal analgesia based on patient's condition, espicially in addicted patients poses clinical challenges to the physicians. The relatively high prevalence of opioid substances can lead to the development of tolerance to this group of drugs in patients (42) . Moreover, different protocols are used in different medical centers for pain management after laparoscopic cholecystectomy. This study aimed to compare the efficacy of diclofenac as a NSAID with the intravenous Meperidine as opioid in pain relief in opioid-dependent (OD) and opioid-independent (OI) patients undergoing laparoscopic cholecystectomy after the surgery.
Methods
This clinical trial was approved by the ethics committee of Birjand University of Medical Sciences with "Ir.Bums.Rec.1394.244" code, and in Iranian registry of clinical trials with "IRCT20140611018063N6" code. The current study was conducted as a single-blinded clinical trial and a patients' pain intensity was evaluated by a nurse who did not know the prescribed drug (blind) using Verbal Rating Scale (VRS) pain scale. The sample size was estimated as 60 patients for each group (120 patients total) based on the study conducted by Soroori et al. (43) , and α=0.05, and β=0.2 were calculated using the following formula:
The study population included the patients diagnosed with gallstones or biliary sludge and requiring surgery who were admitted to Imam Reza hospital in Birjand from November 2015 to April 2016 and all of them underwent laparoscopic cholecystectomy. Participants who were selected by convenience sampling method were enrolled in the study after adjusting for age, gender, and other demographic variables. Thereafter, the participants were provided with the purpose of the study and the written informed consent was obtained from all of them. Exclusion criteria entailed: the presence of laparoscopic cholecystectomy, relative contraindications, such as severe obstructive pulmonary disease, congestive heart failure (EF <20%), acute cholecystitis, gangrenous and empyema gallbladder, intestinal fistula in the biliary tract, obesity, pregnancy, ventriculoperitoneal shunt and cirrhosis, previous abdominal surgery, and appearance of serious drug side effects. The subjects in each group (n=60) were randomly assigned into two equal subgroups (A and B). All patients underwent laparoscopic cholecystectomy under general anesthesia. One subset of each opioiddependent and opioid-independent patients were given 100 mg Diclofenac suppository through the rectal and other subgroups were given 25 mg Downloaded from jsurgery.bums.ac.ir at 16:17 IRDT on Sunday March 22nd 2020 Pain intensity was evaluated by a nurse who was blind to the prescribed drug 24 hours after the administration of drugs using a VRS pain scale. The data were analyzed in SPSS software (version16) regarding descriptive indexes (mean, standard deviation, frequency, and percentage). The relationship between variables was examined using Chi-square and Fisher's exact tests at the significance level of 0.05 (Figure 1 ).
Results
A total of 120 patients participated in the current study after the implementation of the exclusion criteria and all of them completed the study. Based on the obtained results, 43.3 %( n=52) of the participants did not experience any pain after the drug administration (excellent response to the drug), regardless of gender, type of drug and opioid dependency or independency (Table 1) . After separation of patients based on dependency on opioid, 27 patients (45%) in the opioid-independent group did not go through any pain after drug treatment; however, this value was measured at 41.7% in opioid-dependent patients ( Table 2) . Moreover, the separation of patients by (Table 3 ). However, after the separation of patients by opioid independency, as well as types of drugs, it was signified that 90%(n=27) of opioid-independent patients who take diclofenac felt no pain after drug administration, and 8 patients (26.7%) went through mild pain, and none of the patients were painless.
On the other hand, 56.7% (n=17) of diclofenac-user patients in opioid-dependent group experienced mild pain and no one was painless. However, 83.3% (n=25) of opioiddependent patients who consumed Meperidine were painless after taking the drug. Comparison of pain severity after laparoscopic cholecystectomy in opioid-dependent and independent patients between the recipient of Meperidine and diclofenac revealed a significant relationship in 24 hours after surgery (P <0.05) in general Meperidine in opioid-dependent patients and diclofenac in opioid independent patients regarding the relief of pain after laparoscopic cholecystectomy ( Table 4 and 5).
Severity of pain (response to treatment) Frequency Percent
Severe pain (without response) 29 
Discussion
Cholecystitis is the inflammation of the gallbladder which mostly occurs due to the obstruction of the cystic duct by gallstones arising from the gallbladder (5) . Laparoscopic cholecystectomy is considered the gold standard for the surgical treatment of cholecystitis (16) . Although laparoscopic cholecystectomy is associated with less postoperative pain, as compared to open cholecystectomy, it carries its own complications and is not without any pain. Many different analgesic techniques for postlaparoscopy pain relief have been evaluated (22, 23) . Early pain is the most common complaint after laparoscopic cholecystectomy (22, 45) . The present study was conducted on 120 patients (20% male and 80% female). This ratio is justified due to a higher incidence of cholecystitis in women (46) ; however, the subjects' gender little mattered for inclusion in the current study. Nearly half of the patients (43.2%) who underwent laparoscopic cholecystectomy had a good response to prescribed medicines, regardless of gender, type of drug dependence or independence. However, about a quarter of the patients (24.2%) did not respond to these drugs. In other studies, the difference in responses between opioid and nonopioid based drugs has been examined (47) (48) (49) . However, in the current study, we compared their responses between OD and OI patients. in peritoneal with intravenous Meperidine. The findings of this study suggested that oral analgesic requirements after intraperitoneal surgery in bupivacaine group were significantly lower than that of intravenous Meperidine (40) . The results of the study performed by Cheng et al. (39) signified that Celecoxib administration is not effective in the reduction of opioids consumption to ease the pain of patients who had laparoscopic cholecystectomy. On the other hand, a combination of several techniques is more worthwhile in the alleviation of multi-factorial pain following laparoscopic cholecystectomy. In our study, less than half of OD patients with either Meperidine or diclofenac treatment had an excellent response, while more than one-tenth of them had no response to the prescribed drugs. In the case of OI patients, the administration of both Meperidine and diclofenac had an excellent response in nearly half of the patients, while one-third of them had no response to the drug. Regardless of the type of administered drug, prescribed drugs evoked a comparable response in OD and OI patients regarding excellent pain relief. However, the rate of non-response to prescribed drugs in OI patients was reported to be about three times higher than that of OD patients. Regardless of the type of administrated drug, favorable response to treatment regarding the reduction of post-surgical pain after in OI patients was a bit higher, as compared to that of OD patients. On the other hand, the absence of any responses to treatment was about three times higher in OI patients, as compared to OD patients. In general, it was found that the administration of diclofenac in 90% of OI patients resulted in a favorable response and the disappearance of pain.
On the contrary, Meperidine administration evoked favorable responses in 83.3% of OD patients who inflicted no pain. In countries and areas with higher rates of opioid addictions, controlling the pain poses a drastic challenge to the medical team and patients. According to the results of this study, the use of Meperidine is more effective in the reduction of postoperative pain in OI patients, and diclofenac suppository is more worthwhile in OD patients.
It is worthy to note that a review study conducted by Abdolrazaghnejad et al. revealed that among narcotics, morphine can be more appropriate, as compared to Meperidine regarding pain relief, especially in cases where emergency and long-term analgesia is needed (52) .
It can be concluded that regardless of opioid dependency status in patients undergoing laparoscopic cholecystectomy, diclofenac suppository evoked more favorable responses, as compared to intravenous Meperidine regarding the reduction of pain. However, further studies on the effect of these two drugs are commended due to the absence of studies in this field, as well as the importance and limitations of this subject. It is also suggested that future studies use a quantitative scale rather than a qualitative scale to assess pain intensity and examine the pain at different hours of the day. Furthermore, proper studies should be designed and implemented to determine the safety and possible side effects of these drugs for better and more accurate decision-making in the process of treatment.
Conclusions
The results of the current study revealed that non-opioid drugs, such as diclofenac sodium can be used to achieve analgesia in patients and expect favorable results similar to those of opioids, contrary to popular belief in many medical centers and due to the numerous complications of opioids administration. However, in opioid-dependent patients, the results are less satisfactory and sometimes opioid drugs are needed to achieve optimal pain management.
